Conference Reports for NATAP
Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026
Back
 
Tweet
Lenacapavir for PrEP: HIV-1 Incidence and Safety from PURPOSE 2 at the End of Randomized Blinded Phase